Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

chimeric antigen receptor

(ky-MEER-ik AN-tih-jen reh-SEP-ter)
A special receptor created in the laboratory that is designed to bind to certain proteins on cancer cells. The chimeric antigen receptor is then added to immune cells called T cells. This helps the T cells find and kill cancer cells that have the specific protein that the receptor is designed to bind. These changed T cells called chimeric antigen receptor T cells are then grown in large numbers in the laboratory and given to cancer patients. Chimeric antigen receptor T cells are being studied in the treatment of some types of cancer. Also called CAR.
Search NCI's Dictionary of Cancer Terms